Chemical and Nanotechnological Strategies for Enhanced Alopecia Treatment

Volume: 11 | Issue: 02 | Year 2025 | Subscription
International Journal of Analytical and Applied Chemistry
Received Date:
Acceptance Date:
Published On: 2025-09-17
First Page: 1
Last Page: 15

Journal Menu

By:

Student, School of Pharmaceutical Health Science, Atmiya University, Yogidham Gurukul, Kalawad Road, Rajkot, Gujarat, India.
Assistant Professor, School of Pharmaceutical Health Science, Atmiya University, Yogidham Gurukul, Kalawad Road, Rajkot, Gujarat, India.

Abstract

Over 50% of individuals suffer from androgenetic alopecia (AGA), a prevalent cause of hair loss that has historically been treated with oral finasteride and topical minoxidil, however these have inconsistent results. Platelet-rich plasma (PRP), microneedling, and novel medication delivery devices are some of the recent developments in AGA treatment that are intended to enhance therapeutic results and patient satisfaction. To improve hair regrowth, this review looks at new methods that combine cutting-edge microneedling technology with innovative treatments like copper/zinc dual-doped microneedles loaded with quercetin. These methods inhibit dihydrotestosterone and promote follicle regeneration, angiogenesis, and anti-inflammatory effects. While newer methods, like cold atmospheric plasma (CAP) and customized microneedle patches, provide better medication delivery and patient results, combination therapies – such as PRP with minoxidil – show more success than monotherapies in increasing hair density and thickness with certain case studies. However, the necessity for more randomized, controlled research and standardized guidelines is highlighted by differences in treatment methods and the quality of the data. This review demonstrates the potential of combining cutting-edge microneedling technology with conventional therapies, providing a viable path towards more individualized and successful AGA care.

Loading

Citation:

How to cite this article: , Chemical and Nanotechnological Strategies for Enhanced Alopecia Treatment. International Journal of Analytical and Applied Chemistry. 2025; 11(02): 1-15p.

How to cite this URL: , Chemical and Nanotechnological Strategies for Enhanced Alopecia Treatment. International Journal of Analytical and Applied Chemistry. 2025; 11(02): 1-15p. Available from:https://journalspub.com/publication/uncategorized/article=20645

Refrences:

  1. Aff SA, Hassan MA, Abdelhameed AS, Elkhodairy KA. Nanosuspension: an emerging trend for bioavailability enhancement of etodolac. Int J Polym Sci. 2015;2015:Article ID 926128. doi:10.1155/2015/926128.
  2. Aktas H, Alan S, Torkoglu EB, Sevik O. Could topical minoxidil cause non-arteritic anterior ischemic optic neuropathy? J Clin Diagn Res. 2016;10(8):WD01–WD02. doi:10.7860/JCDR/2016/20758.8386.
  3. Alkilani AZ, Nasereddin J, Hamed R, Nimrawi S, Hussein G, Abo-Zour H, et al. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics. 2022;14(6):1152. doi:10.3390/pharmaceutics14061152.
  4. Almeida RFC, Melo DF, Tosti A. Scalp microinfusion: a novel drug delivery technique for hair loss treatment. Skin Appendage Disord. 2023;9(2):81–83. doi:10.1159/000529658.
  5. Alsalhi W, Alalola A, Randolph M, Gwillim E, Tosti A. Novel drug delivery approaches for the management of hair loss. Expert Opin Drug Deliv. 2020;17(3):287–95. doi:10.1080/17425247.2020.1722991.
  6. Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatologic Surgery. 2016;42(4):491–497.
  7. Analysis of Efficacy of Platelet-Rich Plasma Combined with Minoxidil for Androgenetic Alopecia. Aesthetic Plastic Surgery, 1–13.
  8. Andersen V, Anderson J, Wallington T, Mueller S, Nielsen O. Vapor pressures of alcohol–gasoline blends. Energy Fuels. 2010;24(6):3647–54.
  9. Arbache S, Godoy CE. Microinfusion of drugs into the skin with tattoo equipment. Surg Cosmet Dermatol. 2013;5(1):70–4.
  10. Arbache S, Mattos EDC, Diniz MF, Paiva PYA, Roth D, Arbache ST, et al. How much medication is delivered in a novel drug delivery technique that uses a tattoo machine? Int J Dermatol. 2019;58(6):750–5.
  11. Arbache S, Roth D, Steiner D, Breunig J, Michalany NS, Arbache ST, et al. Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary analysis of a randomized, split-body, single-blinded, placebo-controlled clinical trial. J Am Acad Dermatol. 2018;78(1):212–5.
  12. Bloch LD, Sarruf FD. Ciclo de crescimento e queda capilar. In: Damazio MG, Makino RFL, editors. Terapia Capilar: Uma abordagem inter e multidisciplinar. São Paulo: RED Publicações; 2017. p. 37–48.
  13. Bloch LD, Escudeiro CC, Sarruf FD, Valente NYS. Latanoprost and minoxidil: Comparative double-blind, placebo-controlled study for the treatment of hair loss. Surg Cosmet Dermatol. 2017;10(1):39–43.
  14. Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and men. J Dtsch Dermatol Ges. 2011;9(6):S57.
  15. Bougie DW, Peterson J, Rasmussen M, Aster RH. Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa. Blood. 2015;126(19):2146–52.
  16. Chen H, Tang X, Huang Y, Chen C, Yang Y, Hao C, et al. Remodel the perifollicular microenvironment via minoxidil-loaded microneedle patch and cold atmospheric plasma for treating androgenetic alopecia. Nano Res. 2024;1–9.
  17. Chen ZT, Chen GJ, Obenchain R, Zhang R, Bai F, Fang TX, et al. Combination therapy for androgenic alopecia based on quercetin and zinc/copper dual-doped mesoporous silica nanocomposite microneedle patch. Bioact Mater. 2024;24:81–95.
  18. Contin LA. Male androgenetic alopecia treated with microneedling alone or associated with injectable minoxidil by microinfusion of drugs into the skin. Surg Cosmet Dermatol. 2016;8(2):158–61.
  19. Corrêa AC, Machado CJ, Carneiro SC. Split-scalp pilot study to evaluate effectiveness of Minoxidil 0.5% MMP® versus topical minoxidil 5% in the treatment of female pattern hair loss. Arch Dermatol Res. 2024;316(6):313.
  20. Dhurat R, Mathapati S. Response to micro-needling treatment in men with androgenetic alopecia who failed to respond to conventional therapy. Indian J Dermatol. 2015;60(3):260–3.
  21. El-Husseiny RM, Saleh HM, Moustafa AA, Salem SA. Comparison between single- versus double-spin prepared platelet-rich plasma injection in treatment of female pattern hair loss: Clinical effect and relation to vascular endothelial growth factor. Arch Dermatol Res. 2021;313(7):557–66.
  22. Esposito E, Drechsler M, Cortesi R, Nastruzzi C. Encapsulation of cannabinoid drugs in nanostructured lipid carriers. Eur J Pharm Biopharm. 2016;102:87–91.
  23. Essam R, Selim H, Ehab R. The boosting effect of minoxidil 0.1% when combined with dutasteride 0.01% and microneedling in the treatment of female pattern hair loss. J Egypt Womens Dermatol Soc. 2024;21(1):29–35.
  24. Fertig RM, Gamret AC, Cervantes J, Tosti A. Micro-needling for the treatment of hair loss? J Eur Acad Dermatol Venereol. 2018;32(4):564–9.
  25. Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184–9.
  26. Gentile P, Garcovich S. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with Minoxidil, Finasteride, and adult stem cell-based therapy. Int J Mol Sci. 2020;21(8):2702.
  27. Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, Cervelli The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Translational Med. 2015;4(11):1317–1323.
  28. Gupta AK, Renaud HJ, Rapaport JA. Platelet-rich plasma and cell therapy: the new horizon in hair loss treatment. Dermatol Clin. 2021;39(3):429–45.
  29. Hamed R, Alhadidi HF. Minoxidil nanosuspension-loaded dissolved microneedles for hair regrowth. AAPS PharmSciTech. 2024;25(4):Article 75.
  30. Ibrahim TM, Abdallah MH, El-Megrab NA, El-Nahas HM. Upgrading of dissolution and anti-hypertensive effect of carvedilol via two combined approaches: Self-emulsification and liquisolid techniques. Drug Dev Ind Pharm. 2018;44(6):873–85.
  31. Iriarte C, Awosika O, Rengifo-Pardo M, Ehrlich A. Review of applications of micro-needling in dermatology. Clin Cosmet Investig Dermatol. 2017;10:289–98.
  32. Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020;24:1–16.
  33. Jha AK, Vinay K, Zeeshan M, Roy PK, Chaudhary RKP, Priya A. Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil. J Cosmet Dermatol. 2019;18(5):1330–5.
  34. Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ. Treatment of androgenetic alopecia: Current guidance and unmet needs. Clin Cosmet Investig Dermatol. 2023;1387–406.
  35. Kash N, Leavitt M, Leavitt A, Hawkins SD, Roopani RB. Clinical patterns of hair loss in men: Is dihydrotestosterone the only culprit? Dermatol Clin. 2021;39(3):361–70.
  36. Khan A, Agarwal D, Talwar A. Comparison of microneedling with platelet-rich plasma vs minoxidil (5%) + finasteride (0.1%) topical therapy in androgenetic alopecia: A randomized clinical study. J Clin Diagn Res. 2023;17(3):WC01–5.
  37. Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, et al.
  38. Kubba R. Topical minoxidil in androgenetic alopecia: How good is it? Indian J Dermatol Venereol Leprol. 1990;56(3):187–92.
  39. Kumar MK, Inamadar AC, Palit A. A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus micro-needling versus topical minoxidil alone in the treatment of androgenetic alopecia. J Cutan Aesthet Surg. 2018;11(4):211–6.
  40. Kumar S, Ahuja R. The role of peptides in hair restoration. J Dermatolog Treat. 2020;31(4):384–9.
  41. Lee S, Jang M, Ahn H, Kang BM, Yang H, Kang G, et al. Novel treatment of alopecia areata with shooting-type candlelit-dissolving microneedle. Appl Mater Today. 2023;35:101946.
  42. Mahadi AR, Rafi MA, Shahriar T, Seemanta S, Rabbani MG, Akter M, et al. Association between hair diseases and COVID-19 pandemic-related stress: A cross-sectional study analysis. Front Med (Lausanne). 2022;9:876561.
  43. Mella JM, Perret MC, Manzotti M, Catalano HM, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: A systematic review. Arch Dermatol. 2010;146(10):1141–50.
  44. Olsen EA, et al. Standardized photographic evaluation of hair loss. J Am Acad Dermatol. 2021;84(2):373–7.
  45. Orentreich DS, Orentreich N. Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg. 1995;21(6):543–9.
  46. Paichitrojjana A, Paichitrojjana A. Platelet-rich plasma and its use in hair regrowth: A review. Drug Des Devel Ther. 2022;16:635–45.
  47. Patil AS, Hegde R, Gadad AP, Dandagi PM, Masareddy R, Bolmal U. Exploring the solvent-anti-solvent method of nanosuspension for enhanced oral bioavailability of lovastatin. Turk J Pharm Sci. 2021;18(5):541.
  48. Pedroso NM, Mota LR, Pavani C. The use of micro-needling associated with photobiomodulation in the treatment of male androgenetic alopecia: Case series. Int J Case Rep Images. 2019;10:1–6.
  49. Puri N. A study on the efficacy of micro-needling with minoxidil solution versus micro-needling with hair multivitamin solution for the treatment of androgenetic alopecia. Int J Dermatol Clin Res. 2020;6(1):10–12.
  50. Rai PB, Khushwaha P, Jain N, Gupta S. Comparing the therapeutic efficacy of topical minoxidil and finasteride with topical minoxidil and oral finasteride in androgenetic alopecia: A randomized trial. Int J Res Dermatol. 2018;4(3):386–90.
  51. Riangjanapatee P, Khongkow M, Treetong A, Unger O, Phungbun C, Jaemsai S, et al. Development of tea seed oil nanostructured lipid carriers and in vitro studies on their applications in inducing human hair growth. Pharmaceutics. 2022;14(5):984.
  52. Schweiger ES, Boychenko O, Bernstein RM. Update on the pathogenesis, genetics and medical treatment of patterned hair loss. J Drugs Dermatol. 2010;9(11):1412–9.
  53. Shah KB, Shah AN, Solanki RB, Raval RC. A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia. Int J Trichology. 2017;9(1):14–18.
  54. Sharma HK, Chauhan PS, Mehta KS, Mahajan V, Chandel M, Verma Y, et al. A study to compare the efficacy and safety of platelet-rich plasma and topical minoxidil fortified with finasteride in the treatment of androgenic alopecia in male patients. IP Indian J Clin Exp Dermatol. 2022;8(2):91–6.
  55. Shekhter AB, Serezhenkov VA, Rudenko TG, Pekshev AV, Vanin AF. Beneficial effect of gaseous nitric oxide on the healing of skin wounds. Nitric Oxide. 2005;12:210–9.
  56. Singare DS, Marella S, Gowthamrajan K, Kulkarni GT, Vooturi R, Rao PS. Optimization of formulation and process variable of nanosuspension: An industrial perspective. Int J Pharm. 2010;402(1–2):213–20.
  57. Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. Int J Womens Dermatol. 2019;5(1):46–51.
  58. Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: A review. Drug Des Devel Ther. 2019;13:2777–2786.
  59. Taneja S, Shilpi S, Khatri K. Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement. Artif Cells Nanomed Biotechnol. 2016;44(3):978–84.
  60. Tekko IA, Permana AD, Vora L, Hatahet T, McCarthy HO, Donnelly RF. Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis. Eur J Pharm Sci. 2020;152:105469.
  61. Tosti A, Piraccini BM. Androgenetic alopecia. Int J Dermatol. 1999;38(1):1–7.
  62. Tosti A, Iorizzo M. Treatment of alopecia: An update. J Clin Aesthet Dermatol. 2018;11(8):21–9.
  63. Tosti A, Piraccini BM. Androgenetic alopecia. Int J Dermatol. 1999;38(1):1–7.
  64. Uebel CO, Da Silva Junior LL, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg. 2006;118(5):1458–66.
  65. Wang QL, Ren JW, Chen BZ, Jin X, Zhang CY, Guo XD. Effect of humidity on mechanical properties of dissolving microneedles for transdermal drug delivery. J Ind Eng Chem. 2018;59:251–8.
  66. Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172(3):1126–41.
  67. Wei L, Yang Y, Shi K, Wu J, Zhao W, Mo J. Preparation and characterization of loperamide-loaded dynasan 114 solid lipid nanoparticles for increased oral absorption in the treatment of diarrhea. Front Pharmacol. 2016;7:332.
  68. Zhou X, Luo Z, Baidya A, Kim HJ, Wang C, Jiang X, et al. Biodegradable β-cyclodextrin conjugated gelatin methacryloyl microneedle for delivery of water-insoluble drug. Adv Healthc Mater. 2020;9(11):e2000527. doi: 10.1002/adhm.202000527.
  69. Xiao C, Zhang GH, Li HQ, Yang PP, Zhang HB, Mu YX. Meta
  70. Yuan YJ, Wirz RE, Gu Z. Cold atmospheric plasma delivery for biomedical applications. Mater Today. 2022;54:153–188. doi: 10.1016/j.mattod.2021.09.031.
  71. Yan H, Li R, Li Q, Wang J, Gong J. Solubility of minoxidil in methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, and water from (278.15 to 333.15) K. J Chem Eng Data. 2011;56(5):2720–2.
  72. Yang G, Chen Q, Wen D, Chen ZW, Wang JQ, Chen GJ, et al. A therapeutic microneedle patch made from hair-derived keratin for promoting hair regrowth. ACS Nano. 2019;13:4354–60.
  73. Yap CX, Sidorenko J, Wu Y, Kemper KE, Yang J, Wray NR, et al. Dissection of genetic variation and evidence for pleiotropy in male pattern baldness. Nat Commun. 2018;9:5407.
  74. Yuan A, Xia F, Bian Q, Wu H, Gu Y, Wang T, et al. Ceria nanozyme-integrated microneedles reshape the perifollicular microenvironment for androgenetic alopecia treatment. ACS Nano. 2021;15(8):13759–69.
  75. Zhang L, Hu C, Xu W, Wu D, Lei S. Advances in wound repair and regeneration: Systematic comparison of cell-free fat extract and platelet-rich plasma. Front Chem. 2022;10:1089277.
  76. Zhang Y, Chang M, Bao F, Xing M, Wang E, Xu Q, et al. Multifunctional Zn doped hollow mesoporous silica/polycaprolactone electrospun membranes with enhanced hair follicle regeneration and antibacterial activity for wound healing. Nanoscale. 2019;11(13):6315–33.
  77. Zhang Z, Zhang Y, Li W, Ma L, Wang E, Xing M, et al. Curcumin/Fe-SiO2 nanocomposites with multi-synergistic effects for scar inhibition and hair follicle regeneration during burn wound healing. Appl Mater Today. 2021;23:101065.
  78. Zhou Y, Jia L, Zhou D, Chen G, Fu Q, Li N. Advances in microneedles research based on promoting hair regrowth. J Control Release. 2023;353:965–74.

 Previous Article
Next Article